VANCOUVER, BC — Canadian life sciences company Ondine Biomedical has appointed Dr. Simon Sinclair as Chief Medical Officer, as the Company prepares to start the US Phase 3 trial of… Read More
Seeking innovative tech initiatives to execute within the Canadian healthcare ecosystem Challenge application period runs June 1 to June 24, 2023 TORONTO, ON — Takeda Canada Inc. (“Takeda”) is pleased… Read More
SOUTH SAN FRANCISCO, CA and VANCOUVER, BC — /CNW/ — ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate… Read More
VANCOUVER, BC — Bold Therapeutics, a clinical-stage biopharmaceutical company developing first-in-class oncology therapeutics, will be presenting positive interim results in advanced gastric and biliary tract cancer at the 2023 American… Read More
EDMONTON, AB — (BUSINESS WIRE) — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced the results of a post-hoc, pooled analysis of the Phase 2 AURA-LV (NCT02141672)… Read More
